Clinical Trial Update: Investigating Hereditary Risk In Thoracic Cancers (INHERIT)

View source ↗

Summary

A clinical trial named INHERIT is investigating hereditary risk factors for thoracic cancers, currently recruiting participants. The study focuses on lung cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Lung Cancer, Genetic Disease | Status: RECRUITING